Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |